Publications found:
385
Sort by:
Neurodegenerative Disease Therapeutics Market - 2024-2033
US$ 2,999.00
The Neurodegenerative Disease Therapeutics Market was valued at US$ 12.52 Billion in 2024 and is anticipated to reach US$ 28.78 Billion by 2033, at a CAGR of 0.098 from 2026 to 2032. The report delive...
January 2026
210 pages
Clinically Isolated Syndrome Treatment Market 2026
US$ 2,999.00
The Clinically Isolated Syndrome Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics,...
December 2025
207 pages
Cluster Headache Market 2026
US$ 2,999.00
The Cluster Headache Market was valued at in and is anticipated to reach by , at a CAGR of 0.0755 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
December 2025
220 pages
Migraine Nasal Spray Market 2026
US$ 2,999.00
The Migraine Nasal Spray Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
December 2025
200 pages
Muscle Spasticity Market - 2022-2030
US$ 2,999.00
The Muscle Spasticity Market was valued at US$ 4.2 billion in 2022 and is anticipated to reach US$ 7.7 billion by 2030, at a CAGR of 0.081 from 2026 to 2032. The report delivers in-depth insights into...
December 2025
243 pages
Opioid Use Disorder Drugs Market - 2022-2030
US$ 2,999.00
The Opioid Use Disorder Drugs Market was valued at US$ 2.9 billion in 2022 and is anticipated to reach US$ 6.1 billion by 2030, at a CAGR of 0.101 from 2026 to 2032. The report delivers in-depth insig...
December 2025
207 pages
Rare Neurological Disease Drugs Market - 2023-2031
US$ 2,999.00
The Rare Neurological Disease Drugs Market was valued at US$ 139.4 billion in 2023 and is anticipated to reach US$ 269.7 billion by 2031, at a CAGR of 0.086 from 2026 to 2032. The report delivers in-d...
December 2025
200 pages
Gabapentin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Form (Tablet, Capsule, Oral Solution), By Type (Generic, Branded), By Application (Epilepsy, Neuropathic Pain, Restless Legs Syndrome, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Gabapentin Market, valued at USD 2.04 Billion in 2024, is projected to experience a CAGR of 5.60% to reach USD 2.83 Billion by 2030. Gabapentin, an anticonvulsant medication, is primarily u...
December 2025
185 pages
Autism Spectrum Disorders Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Antipsychotic Drugs, Selective Serotonin Reuptake Inhibitors, Stimulants, Sleep Medication, Others), By Application (Autistic Disorder, Asperger Syndrome, Pervasive Development Disorder, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Autism Spectrum Disorders Treatment Market, valued at USD 1.71 Billion in 2024, is projected to experience a CAGR of 5.39% to reach USD 2.34 Billion by 2030. The Global Autism Spectrum Diso...
December 2025
185 pages
Acetylcholinesterase Inhibitors Market - 2023-2031
US$ 2,999.00
The Acetylcholinesterase Inhibitors Market was valued at US$ 5.03 billion in 2023 and is anticipated to reach US$ 9.03 billion by 2031, at a CAGR of 0.078 from 2026 to 2032. The report delivers in-dep...
November 2025
210 pages
Acute Migraine Drugs Market - 2022-2030
US$ 2,999.00
The Acute Migraine Drugs Market was valued at US$ 10.1 billion in 2022 and is anticipated to reach US$ 18.6 billion by 2030, at a CAGR of 0.081 from 2026 to 2032. The report delivers in-depth insights...
November 2025
207 pages
Alcohol Use Disorder Treatment Market 2026
US$ 2,999.00
The Alcohol Use Disorder Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
November 2025
220 pages
Anti-Suicide Drugs Market - 2023-2031
US$ 2,999.00
The Anti-Suicide Drugs Market was valued at US$ 97.2 billion in 2023 and is anticipated to reach US$ 136.4 billion by 2031, at a CAGR of 0.045 from 2026 to 2032. The report delivers in-depth insights...
November 2025
210 pages
Antidepressant Drugs Market - 2022-2031
US$ 2,999.00
The Antidepressant Drugs Market was valued at US$ 14.3 billion in 2022 and is anticipated to reach US$ 20.6 billion by 2031, at a CAGR of 0.0556 from 2026 to 2032. The report delivers in-depth insight...
November 2025
243 pages
Antiepileptic Drugs Market 2026
US$ 2,999.00
The Antiepileptic Drugs Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
200 pages
Dravet Syndrome Therapeutics Market 2026
US$ 2,999.00
The Dravet Syndrome Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of 0.115 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
November 2025
243 pages
Drug-Resistant Epilepsy Market - 2022-2030
US$ 2,999.00
The Drug-Resistant Epilepsy Market was valued at US$ 0.78 billion in 2022 and is anticipated to reach US$ 1.1 billion by 2030, at a CAGR of 0.044 from 2026 to 2032. The report delivers in-depth insigh...
November 2025
223 pages
Dysthymia Drugs Market 2026
US$ 2,999.00
The Dysthymia Drugs Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional grow...
November 2025
210 pages
Edaravone Market 2026
US$ 2,999.00
The Edaravone Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth tre...
November 2025
220 pages
Europe Acute Schizophrenia Treatment Market 2026
US$ 2,999.00
The Europe Acute Schizophrenia Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, in...
November 2025
217 pages
Gamma-Aminobutyric Acid (GABA) Receptor Market 2026
US$ 2,999.00
The Gamma-Aminobutyric Acid (GABA) Receptor Market was valued at in and is anticipated to reach by , at a CAGR of 0.045 from 2026 to 2032. The report delivers in-depth insights into key market dynamic...
November 2025
217 pages
Infantile Spasm Market 2026
US$ 2,999.00
The Infantile Spasm Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional grow...
November 2025
200 pages
Insomnia Treatment Market - 2022-2031
US$ 2,999.00
The Insomnia Treatment Market was valued at US$ 3.7 billion in 2022 and is anticipated to reach US$ 5.1 billion by 2031, at a CAGR of 0.043 from 2026 to 2032. The report delivers in-depth insights int...
November 2025
200 pages
Neurodegenerative Disease Market 2026
US$ 2,999.00
The Neurodegenerative Disease Market was valued at in and is anticipated to reach by , at a CAGR of 0.0745 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...
November 2025
219 pages
Neuromyelitis Optica (Devic's Syndrome) Market 2026
US$ 2,999.00
The Neuromyelitis Optica (Devic's Syndrome) Market was valued at in and is anticipated to reach by , at a CAGR of 0.048 from 2026 to 2032. The report delivers in-depth insights into key market dynamic...
November 2025
219 pages
Neuroprotection Market 2026
US$ 2,999.00
The Neuroprotection Market was valued at in and is anticipated to reach by , at a CAGR of 0.082 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gr...
November 2025
223 pages
Opioids Drug Market - 2022
US$ 2,999.00
The Opioids Drug Market was valued at USD 39.2 billion in 2022 and is anticipated to reach by , at a CAGR of 0.033 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, in...
November 2025
218 pages
Peripheral Neuropathy Market - 2021
US$ 2,999.00
The Peripheral Neuropathy Market was valued at US$ 1,539 million in 2021 and is anticipated to reach by , at a CAGR of 0.042 from 2026 to 2032. The report delivers in-depth insights into key market dy...
November 2025
207 pages
Postpartum Depression Market 2026
US$ 2,999.00
The Postpartum Depression Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regiona...
November 2025
220 pages
Pregabalin Market 2026
US$ 2,999.00
The Pregabalin Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth tr...
November 2025
220 pages
Progressive Supranuclear Palsy Therapeutics Market 2026
US$ 2,999.00
The Progressive Supranuclear Palsy Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynam...
November 2025
218 pages
Refractory Epilepsy Treatment Market - 2023-2031
US$ 2,999.00
The Refractory Epilepsy Treatment Market was valued at US$ 3.97 billion in 2023 and is anticipated to reach US$ 5.78 billion by 2031, at a CAGR of 0.048 from 2026 to 2032. The report delivers in-depth...
November 2025
210 pages
Refractory Status Drugs Epileptics Market 2026
US$ 2,999.00
The Refractory Status Drugs Epileptics Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, incl...
November 2025
223 pages
Substance Abuse Treatment Market 2026
US$ 2,999.00
The Substance Abuse Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including reg...
November 2025
200 pages
Tardive Dyskinesia Treatment Market 2026
US$ 2,999.00
The Tardive Dyskinesia Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.04 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...
November 2025
223 pages
Tourette Syndrome Market 2026
US$ 2,999.00
The Tourette Syndrome Market was valued at in and is anticipated to reach by , at a CAGR of 0.105 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
200 pages
Traumatic Brain Injury Therapeutics Market 2026
US$ 2,999.00
The Traumatic Brain Injury Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of 0.049 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, i...
November 2025
243 pages
Treatment-Resistant Depression Market 2026
US$ 2,999.00
The Treatment-Resistant Depression Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
November 2025
218 pages
US Tardive Dyskinesia Treatment Market - 2031-2023
US$ 2,999.00
The US Tardive Dyskinesia Treatment Market was valued at US$ 6417.43 million in 2031 and is anticipated to reach US$ 3061.64 million by 2023, at a CAGR of 0.098 from 2026 to 2032. The report delivers...
November 2025
223 pages
U.S. Autism Spectrum Disorder Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Antipsychotic Drugs, Stimulants, Sleep Medications, Selective Serotonin Reuptake Inhibitors), By Application, By Distribution Channel, And Segment Forecasts, 2025 - 2033
US$ 3,950.00
The U.S. autism spectrum disorder treatment market size was estimated at USD 827.84 million in 2024 and is projected to reach USD 1,431.60 million by 2033, growing at a CAGR of 6.30% from 2025 to 2033...
November 2025
120 pages
Insomnia Drug Market Outlook 2026-2034: Market Share, and Growth Analysis By Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists, Others), By Application (Over-the- Counter Drugs, Prescription Drugs), By Distribution Channel
US$ 3,950.00
The Insomnia Drug Market is valued at USD 2.95 billion in 2025 and is projected to grow at a CAGR of 5.1% to reach USD 4.62 billion by 2034. Insomnia Drug Market The Insomnia Drug market spans prescri...
November 2025
160 pages
Benzodiazepine Drugs Market Size, Share & Trends Analysis Report By Application (Anxiety Disorders, Insomnia & Sleep Disorders), By Product (Diazepam, Lorazepam, Alprazolam, Clonazepam), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global benzodiazepine drugs market size was estimated at USD 2.83 billion in 2024 and is projected to reach USD 3.85 billion by 2033, growing at a CAGR of 3.48% from 2025 to 2033. The industry is...
November 2025
150 pages
